Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells

Melanie T. Hartsough, Kathleen Mulder

Research output: Contribution to journalArticle

262 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) is a potent growth inhibitor of a variety of epithelial cell types. The primary signaling mechanism involved in mediating this and other cellular effects of TGF-β is still unknown. We report here that both TGF-β1 and TGF-β2 resulted in a rapid activation of mitogen-activated protein kinase (MAPK) p44mapk, occurring within 5-10 min of growth factor addition. This effect occurred in exponentially proliferating cultures of intestinal epithelial (IEC) 4-1 cells under conditions in which DNA synthesis was inhibited by 95% to 98%. Furthermore, TGF-β2 induced a sustained activation of p44mapk under these conditions, lasting for at least 90 min after initial growth factor treatment. Another TGF-β-sensitive epithelial cell line (CCL 64) displayed a similar rapid increase in p44mapk activity when treated with TGF-β1. In contrast, in IEC 4-6 cells that are resistant to TGF-β effects on growth and DNA synthesis, TGF-β2 treatment did not result in an activation of p44mapk. In contrast to the results in proliferating cultures, treatment of quiescent cultures of IEC 4-1 cells with TGF-β2 resulted in no significant change in either DNA synthesis or p44mapk activity within 15 min of TGF-β addition. In contrast, addition of the growth-stimulatory combination of factors (epidermal growth factor + insulin + transferrin = EIT) to quiescent and proliferating IEC 4-1 cells stimulated DNA synthesis and resulted in a sustained activation of p44mapk. Together, our results suggest an association between activation of p44mapk and both TGF-β-mediated growth inhibition and EIT-mediated growth stimulation. This suggests that the specificity for the cellular effects of growth factors may not occur at the level of MAPK activation per se, but rather at downstream events that include phosphorylation of distinct transcriptional complexes and activation of a select assortment of genes. With regard to TGF-β specifically, we have proposed a model to explain how activation of p44mapk may be associated with a growth-inhibitory response.

Original languageEnglish (US)
Pages (from-to)7117-7124
Number of pages8
JournalJournal of Biological Chemistry
Volume270
Issue number13
DOIs
StatePublished - Mar 31 1995

Fingerprint

Transforming Growth Factors
Epithelial Cells
Chemical activation
Growth
Intercellular Signaling Peptides and Proteins
DNA
Mitogen-Activated Protein Kinases
Growth Inhibitors
Phosphorylation
Transferrin
Epidermal Growth Factor
Transcriptional Activation
Genes
Association reactions

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{20369ca57fe74218a8e97383978b9fa4,
title = "Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells",
abstract = "Transforming growth factor-β (TGF-β) is a potent growth inhibitor of a variety of epithelial cell types. The primary signaling mechanism involved in mediating this and other cellular effects of TGF-β is still unknown. We report here that both TGF-β1 and TGF-β2 resulted in a rapid activation of mitogen-activated protein kinase (MAPK) p44mapk, occurring within 5-10 min of growth factor addition. This effect occurred in exponentially proliferating cultures of intestinal epithelial (IEC) 4-1 cells under conditions in which DNA synthesis was inhibited by 95{\%} to 98{\%}. Furthermore, TGF-β2 induced a sustained activation of p44mapk under these conditions, lasting for at least 90 min after initial growth factor treatment. Another TGF-β-sensitive epithelial cell line (CCL 64) displayed a similar rapid increase in p44mapk activity when treated with TGF-β1. In contrast, in IEC 4-6 cells that are resistant to TGF-β effects on growth and DNA synthesis, TGF-β2 treatment did not result in an activation of p44mapk. In contrast to the results in proliferating cultures, treatment of quiescent cultures of IEC 4-1 cells with TGF-β2 resulted in no significant change in either DNA synthesis or p44mapk activity within 15 min of TGF-β addition. In contrast, addition of the growth-stimulatory combination of factors (epidermal growth factor + insulin + transferrin = EIT) to quiescent and proliferating IEC 4-1 cells stimulated DNA synthesis and resulted in a sustained activation of p44mapk. Together, our results suggest an association between activation of p44mapk and both TGF-β-mediated growth inhibition and EIT-mediated growth stimulation. This suggests that the specificity for the cellular effects of growth factors may not occur at the level of MAPK activation per se, but rather at downstream events that include phosphorylation of distinct transcriptional complexes and activation of a select assortment of genes. With regard to TGF-β specifically, we have proposed a model to explain how activation of p44mapk may be associated with a growth-inhibitory response.",
author = "Hartsough, {Melanie T.} and Kathleen Mulder",
year = "1995",
month = "3",
day = "31",
doi = "10.1074/jbc.270.13.7117",
language = "English (US)",
volume = "270",
pages = "7117--7124",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "13",

}

Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells. / Hartsough, Melanie T.; Mulder, Kathleen.

In: Journal of Biological Chemistry, Vol. 270, No. 13, 31.03.1995, p. 7117-7124.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells

AU - Hartsough, Melanie T.

AU - Mulder, Kathleen

PY - 1995/3/31

Y1 - 1995/3/31

N2 - Transforming growth factor-β (TGF-β) is a potent growth inhibitor of a variety of epithelial cell types. The primary signaling mechanism involved in mediating this and other cellular effects of TGF-β is still unknown. We report here that both TGF-β1 and TGF-β2 resulted in a rapid activation of mitogen-activated protein kinase (MAPK) p44mapk, occurring within 5-10 min of growth factor addition. This effect occurred in exponentially proliferating cultures of intestinal epithelial (IEC) 4-1 cells under conditions in which DNA synthesis was inhibited by 95% to 98%. Furthermore, TGF-β2 induced a sustained activation of p44mapk under these conditions, lasting for at least 90 min after initial growth factor treatment. Another TGF-β-sensitive epithelial cell line (CCL 64) displayed a similar rapid increase in p44mapk activity when treated with TGF-β1. In contrast, in IEC 4-6 cells that are resistant to TGF-β effects on growth and DNA synthesis, TGF-β2 treatment did not result in an activation of p44mapk. In contrast to the results in proliferating cultures, treatment of quiescent cultures of IEC 4-1 cells with TGF-β2 resulted in no significant change in either DNA synthesis or p44mapk activity within 15 min of TGF-β addition. In contrast, addition of the growth-stimulatory combination of factors (epidermal growth factor + insulin + transferrin = EIT) to quiescent and proliferating IEC 4-1 cells stimulated DNA synthesis and resulted in a sustained activation of p44mapk. Together, our results suggest an association between activation of p44mapk and both TGF-β-mediated growth inhibition and EIT-mediated growth stimulation. This suggests that the specificity for the cellular effects of growth factors may not occur at the level of MAPK activation per se, but rather at downstream events that include phosphorylation of distinct transcriptional complexes and activation of a select assortment of genes. With regard to TGF-β specifically, we have proposed a model to explain how activation of p44mapk may be associated with a growth-inhibitory response.

AB - Transforming growth factor-β (TGF-β) is a potent growth inhibitor of a variety of epithelial cell types. The primary signaling mechanism involved in mediating this and other cellular effects of TGF-β is still unknown. We report here that both TGF-β1 and TGF-β2 resulted in a rapid activation of mitogen-activated protein kinase (MAPK) p44mapk, occurring within 5-10 min of growth factor addition. This effect occurred in exponentially proliferating cultures of intestinal epithelial (IEC) 4-1 cells under conditions in which DNA synthesis was inhibited by 95% to 98%. Furthermore, TGF-β2 induced a sustained activation of p44mapk under these conditions, lasting for at least 90 min after initial growth factor treatment. Another TGF-β-sensitive epithelial cell line (CCL 64) displayed a similar rapid increase in p44mapk activity when treated with TGF-β1. In contrast, in IEC 4-6 cells that are resistant to TGF-β effects on growth and DNA synthesis, TGF-β2 treatment did not result in an activation of p44mapk. In contrast to the results in proliferating cultures, treatment of quiescent cultures of IEC 4-1 cells with TGF-β2 resulted in no significant change in either DNA synthesis or p44mapk activity within 15 min of TGF-β addition. In contrast, addition of the growth-stimulatory combination of factors (epidermal growth factor + insulin + transferrin = EIT) to quiescent and proliferating IEC 4-1 cells stimulated DNA synthesis and resulted in a sustained activation of p44mapk. Together, our results suggest an association between activation of p44mapk and both TGF-β-mediated growth inhibition and EIT-mediated growth stimulation. This suggests that the specificity for the cellular effects of growth factors may not occur at the level of MAPK activation per se, but rather at downstream events that include phosphorylation of distinct transcriptional complexes and activation of a select assortment of genes. With regard to TGF-β specifically, we have proposed a model to explain how activation of p44mapk may be associated with a growth-inhibitory response.

UR - http://www.scopus.com/inward/record.url?scp=0028937610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028937610&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.13.7117

DO - 10.1074/jbc.270.13.7117

M3 - Article

C2 - 7706248

AN - SCOPUS:0028937610

VL - 270

SP - 7117

EP - 7124

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 13

ER -